Bolster AI on September 3, 2026 published research reporting that a Tor-hosted marketplace selling counterfeit currency manufactured the appearance of…
Category: Unite.AI
DJI Launches ROMO 2 Robot Vacuum Series Globally
DJI launched the ROMO 2 series globally on September 3, 2026, introducing two new robot vacuum and mop models, the ROMO P2 and ROMO A2. The Shenzhen-based…
Your Fraud Stack Was Built For Human Adversaries
For the last 30 years, CAPTCHA has done one job: make a machine fail a test that a person passes without thinking. That job is over. Researchers, testing…
Keeping PHI Secure in Untethered Employee Benefits Platforms
The integration of artificial intelligence into HR and employee benefits administration has fundamentally changed how healthcare benefits are managed and…
Cango’s EcoHash Begins Commercial GPU Compute at Georgia AI Facility
Cango Inc. said its high-performance computing and AI inference subsidiary, EcoHash Technology LLC, completed dedicated AI infrastructure modifications at…
Superluminal Medicines Raises $60M Series B to Advance Obesity Drug
Superluminal Medicines, a Boston biotechnology company applying AI and machine learning to drug discovery, announced on September 3, 2026 the closing of…
LITEON Invests $176M via Strategic Investment for 25% Stake in DCX Liquid Cooling Systems
LITEON Technology announced on September 3, 2026, a strategic investment in DCX Liquid Cooling Systems, a Warsaw, Poland-based provider of advanced liquid…
UKHSA: Sleep App Cough Data Signals Flu and COVID-19 a Week Early
The UK Health Security Agency and Swedish sleep technology company Sleep Cycle on September 3, 2026 published the results of a joint research study…
Sivers Commits $30M to Glasgow InP Laser Expansion for AI Datacenter Ramp
Sivers Semiconductors AB said on September 3, 2026, that it will invest USD 30 million to expand its Indium Phosphide (InP) manufacturing facility in…
JapanFold Keeps Open-Source Drug Discovery Computations Inside Japan
ai& and Tenstorrent launched JapanFold on September 3, 2026, a drug discovery platform serving open-source structural biology models entirely on…